home / stock / cycc / cycc news

CYCC News and Press, Cyclacel Pharmaceuticals Inc.

Stock Information
Company Name: Cyclacel Pharmaceuticals Inc.
Stock Symbol: CYCC
Market: NASDAQ
Website: cyclacel.com
Menu
CYCC CYCC Quote CYCC Short CYCC News CYCC Articles CYCC Message Board
Get CYCC Alerts

News, Short Squeeze, Breakout and More Instantly...
CYCC - Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the receipt of a notice from the European ...
CYCC - Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”...

CYCC - Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib's Potential as a Precision Medicine for Cancer

- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;...

CYCC - US Companies Moving the Markets, Evening edition
Fri, May 31, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Novo Integrated Sciences Inc. (NVOS) rose 132.8% to $1.05 on volume of 308,155,573 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.9% to $0.0387 on volume of 278,348,616 shares Faraday Future Intelligent Electric Inc. (FFIE) ...
CYCC - Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript

2024-05-14 20:08:02 ET Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript May 14, 2024, 04:30 PM ET Company Participants Grace Kim - IR Spiro Rombotis - President and CEO Brian Schwartz - CMO Paul McBarron - EVP, Finance & COO Co...

CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$2.27 beats by $2.48

2024-05-14 16:53:41 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34 Cyclacel Pharmaceuticals receives $2.9M R&D tax credit Seeking Alpha...

CYCC - APP, MGNX and CYCC among pre-market losers

2024-05-14 08:25:47 ET More on pre-market losers & stocks. MacroGenics: Strong Likelihood Bad News Has Caused Overreaction (Rating Upgrade) AppLovin: Remains A 'Strong Buy' After Post-Earnings Surge (SA Quant) MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call Transc...
CYCC - AMC, LAZR and OCGN are among premarket gainers

2024-05-13 08:23:20 ET More on premarket gainers & stock Spotlight On The CPI Print, Walmart Earnings, Google Event And Zeekr Buzz Luminar's Q1 Results: Financial Struggles And Strategic Moves AMC Entertainment Holdings, Inc. (AMC) Q1 2024 Earnings Call Transcrip...

CYCC - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

CYCC - Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesd...
Next 10